John Varga
University of Michigan · 443 works · 33,445 citations · h-index 95
Top works
- 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
- Cyclophosphamide versus Placebo in Scleroderma Lung Disease
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
- Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts
- Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.
- Systemic sclerosis: a prototypic multisystem fibrotic disorder
- Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
- Recent Developments in Myofibroblast Biology
- Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-β
- Systemic Sclerosis after Augmentation Mammoplasty with Silicone Implants
- High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial
- Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3
- Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study
- Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease
- Systemic sclerosis
- Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trial
- Evaluation of Transforming Growth Factor β and Type I Procollagen Gene Expression in Fibrotic Skin Disease by In Situ Hybridization
- Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria